15-75018813-G-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_138967.4(SCAMP5):c.538G>T(p.Gly180Trp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_138967.4 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Illumina
- epilepsyInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCAMP5 | NM_138967.4 | c.538G>T | p.Gly180Trp | missense_variant | Exon 7 of 7 | ENST00000425597.8 | NP_620417.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:2Uncertain:1
- -
Published functional studies using Drosophila fly models showed reduced protein levels and suggested a dominant-negative effect (Hubert et al., 2020); Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 33663553, 33390987, 31439720) -
- -
Global developmental delay Pathogenic:1
The variant has been previously reported as de novo insimilarly affected unrelated individual (PMID:31439720, PS2). It is not observed in the gnomAD v2.1.1 dataset (PM2). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.649, 3Cnet: 0.848, PP3). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. -
Macrocephaly-developmental delay syndrome Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
The c.538G>T (p.G180W) alteration is located in exon 8 (coding exon 6) of the SCAMP5 gene. This alteration results from a G to T substitution at nucleotide position 538, causing the glycine (G) at amino acid position 180 to be replaced by a tryptophan (W). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration has been reported as de novo in multiple unrelated patients with seizures, developmental delay, intellectual disability, and abnormal neurological exam findings. Some patients were also reported to have autism spectrum disorder and/or dysmorphic facial features (Hubert, 2020; Jiao 2020). This amino acid position is highly conserved in available vertebrate species. Functional analysis demonstrated that the p.G180W alteration decreased protein levels compared to wild type protein when expressed in the Drosophila fat body using the corresponding alteration, p.G302W, in the fly homolog. Additionally, expression of the p.G302W alteration in Drosophila showed abnormal eye formation and disturbed the normal fly neurological phenotype (Hubert, 2020). The in silico prediction for this alteration is inconclusive. Based on the available evidence, this alteration is classified as pathogenic. -
SCAMP5-related neurodevelopmental disorder with autistic features and seizures Pathogenic:1
The SCAMP5 c.538G>T (p.Gly180Trp) missense variant has been reported in a de novo state in six unrelated individuals with developmental delay, seizures, motor disorders, behavioral differences, and abnormalities on brain MRI (PMID: 31439720; 33390987). This variant is not observed in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. Functional studies of this variant conducted in a Drosophila knock-in model suggest it has a dominant-negative effect (PMID: 31439720). This variant has been classified as pathogenic or likely pathogenic by four submitters in ClinVar. Based on the available evidence, the c.538G>T (p.Gly180Trp) variant is classified as likely pathogenic for SCAMP5-related neurodevelopmental disorder with autistic features and seizures. -
SCAMP5-related neurodevelopmental and movement disorder Other:1
Variant classified as Pathogenic and reported on 01-17-2023 by GeneDx. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at